Stock PANG PANGAEA ONCOLOGY, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Pangaea Oncology, S.A.

Equities

PANG

ES0105221008

Delayed BME
Other stock markets
 10:00:08 2024-04-30 am EDT 		5-day change 1st Jan Change
1.75 EUR -.--% Intraday chart for Pangaea Oncology, S.A. +1.16% -4.89%
2023 Pangaea Oncology, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
2023 Pangaea Oncology, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pangaea Oncology, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Pangaea Oncology, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Pangaea Oncology, S.A. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Pangaea Oncology, S.A. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Pangaea Oncology, S.A. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Vidaro Inversiones S.L. acquired 6.62% stake in Pangaea Oncology, S.A. from HERSOL XXI, SL for €1.5 million.
CI
HERSOL XXI, SL acquired an additional 0.6% stake in Pangaea Oncology, S.A. from director of Grupo Pikolin, S.L. for €0.15 million.
CI
GrupoPikolin, S.L. acquired 24.94% stake in Pangaea Oncology, S.A. from Mercantile Ebrosol Inversiones, S.L.U.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PANG Stock
  4. News Pangaea Oncology, S.A.
  5. Highlights